Modeling hepatitis C virus kinetics during liver transplantation reveals the role of the liver in virus clearance

  1. Louis Shekhtman
  2. Miquel Navasa
  3. Natasha Sansone
  4. Gonzalo Crespo
  5. Gitanjali Subramanya
  6. Tje Lin Chung
  7. E Fabian Cardozo-Ojeda
  8. Sofia Pérez-del-Pulgar
  9. Alan S Perelson
  10. Scott J Cotler
  11. Xavier Forns
  12. Susan L Uprichard  Is a corresponding author
  13. Harel Dahari  Is a corresponding author
  1. Loyola University Medical Center, Stritch School of Medicine, United States
  2. University of Barcelona, Spain
  3. University of Illinois, Chicago, United States
  4. Fred Hutchinson Cancer Research Center, United States
  5. Los Alamos National Laboratory, United States

Abstract

While the liver, specifically hepatocytes, are widely accepted as the main source of hepatitis C virus (HCV) production, the role of the liver/hepatocytes in clearance of circulating HCV remains unknown. Frequent HCV kinetic data were recorded and mathematically modeled from 5 liver-transplant patients throughout the anhepatic (absence of liver) phase and for 4 hours post-reperfusion. During the anhepatic phase, HCV remained at pre-anhepatic levels (n=3) or declined (n=2) with t1/2~1h. Immediately post-reperfusion, virus declined in a biphasic manner in 4 patients consisting of a rapid decline (t1/2=5min) followed by a slower decline (t1/2=67min). Consistent with the majority of patients in the anhepatic phase, when we monitored HCV clearance at 37°C from culture medium in the absence/presence of chronically infected hepatoma cells that were inhibited from secreting HCV, the HCV t1/2 in cell culture was longer in the absence of chronically HCV-infected cells. The results suggest that the liver plays a major role in the clearance of circulating HCV and that hepatocytes may be involved.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files

Article and author information

Author details

  1. Louis Shekhtman

    Division of Hepatology, Department of Medicine, Loyola University Medical Center, Stritch School of Medicine, Maywood, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5273-8363
  2. Miquel Navasa

    Liver Unit, Hospital Clínic, IDIBAPS and CIBEREHD, University of Barcelona, Barcelona, Spain
    Competing interests
    No competing interests declared.
  3. Natasha Sansone

    Department of Microbiology and Immunology, University of Illinois, Chicago, Chicago, United States
    Competing interests
    No competing interests declared.
  4. Gonzalo Crespo

    Liver Unit, Hospital Clínic, IDIBAPS and CIBEREHD, University of Barcelona, Barcelona, Spain
    Competing interests
    No competing interests declared.
  5. Gitanjali Subramanya

    Division of Hepatology, Department of Medicine, Loyola University Medical Center, Stritch School of Medicine, Maywood, United States
    Competing interests
    No competing interests declared.
  6. Tje Lin Chung

    Division of Hepatology, Department of Medicine, Loyola University Medical Center, Stritch School of Medicine, Maywood, United States
    Competing interests
    No competing interests declared.
  7. E Fabian Cardozo-Ojeda

    Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8690-9896
  8. Sofia Pérez-del-Pulgar

    Liver Unit, Hospital Clínic, IDIBAPS and CIBEREHD, University of Barcelona, Barcelona, Spain
    Competing interests
    No competing interests declared.
  9. Alan S Perelson

    Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, United States
    Competing interests
    No competing interests declared.
  10. Scott J Cotler

    Division of Hepatology, Department of Medicine, Loyola University Medical Center, Stritch School of Medicine, Maywood, United States
    Competing interests
    No competing interests declared.
  11. Xavier Forns

    3Liver Unit, Hospital Clínic, IDIBAPS and CIBEREHD, University of Barcelona, Barcelona, Spain
    Competing interests
    Xavier Forns, XF acted as advisor for Gilead and AbbVie.
  12. Susan L Uprichard

    Division of Hepatology, Department of Medicine, Loyola University Medical Center, Stritch School of Medicine, Maywood, United States
    For correspondence
    suprichard@luc.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5691-1557
  13. Harel Dahari

    Division of Hepatology, Department of Medicine, Loyola University Medical Center, Stritch School of Medicine, Maywood, United States
    For correspondence
    hdahari@luc.edu
    Competing interests
    No competing interests declared.

Funding

National Institute of Allergy and Infectious Diseases (R01-AI078881)

  • Susan L Uprichard

National Institute of Allergy and Infectious Diseases (R01-AI116868)

  • Alan S Perelson

Instituto de Salud Carlos III (PI15/00151 and PI13/00155)

  • Xavier Forns

Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement (grant 2017_SGR_1753)

  • Xavier Forns

CERCA Programme/Generalitat de Catalunya

  • Xavier Forns

Germany Academic Exchange Service

  • Tje Lin Chung

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Niel Hens, Hasselt University, Belgium

Ethics

Human subjects: The study was approved by the Ethics Committee at Hospital Clinic Barcelona (Record 2010/5810) and all patients provided a written informed consent.

Version history

  1. Preprint posted: August 4, 2020 (view preprint)
  2. Received: November 29, 2020
  3. Accepted: November 1, 2021
  4. Accepted Manuscript published: November 3, 2021 (version 1)
  5. Version of Record published: November 22, 2021 (version 2)

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 505
    views
  • 80
    downloads
  • 4
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Louis Shekhtman
  2. Miquel Navasa
  3. Natasha Sansone
  4. Gonzalo Crespo
  5. Gitanjali Subramanya
  6. Tje Lin Chung
  7. E Fabian Cardozo-Ojeda
  8. Sofia Pérez-del-Pulgar
  9. Alan S Perelson
  10. Scott J Cotler
  11. Xavier Forns
  12. Susan L Uprichard
  13. Harel Dahari
(2021)
Modeling hepatitis C virus kinetics during liver transplantation reveals the role of the liver in virus clearance
eLife 10:e65297.
https://doi.org/10.7554/eLife.65297

Share this article

https://doi.org/10.7554/eLife.65297

Further reading

    1. Microbiology and Infectious Disease
    2. Structural Biology and Molecular Biophysics
    Alexander D Cook, Mark Carrington, Matthew K Higgins
    Research Article

    African trypanosomes replicate within infected mammals where they are exposed to the complement system. This system centres around complement C3, which is present in a soluble form in serum but becomes covalently deposited onto the surfaces of pathogens after proteolytic cleavage to C3b. Membrane-associated C3b triggers different complement-mediated effectors which promote pathogen clearance. To counter complement-mediated clearance, African trypanosomes have a cell surface receptor, ISG65, which binds to C3b and which decreases the rate of trypanosome clearance in an infection model. However, the mechanism by which ISG65 reduces C3b function has not been determined. We reveal through cryogenic electron microscopy that ISG65 has two distinct binding sites for C3b, only one of which is available in C3 and C3d. We show that ISG65 does not block the formation of C3b or the function of the C3 convertase which catalyses the surface deposition of C3b. However, we show that ISG65 forms a specific conjugate with C3b, perhaps acting as a decoy. ISG65 also occludes the binding sites for complement receptors 2 and 3, which may disrupt recruitment of immune cells, including B cells, phagocytes, and granulocytes. This suggests that ISG65 protects trypanosomes by combining multiple approaches to dampen the complement cascade.

    1. Microbiology and Infectious Disease
    Michael D Sacco, Lauren R Hammond ... Yu Chen
    Research Article

    In the Firmicutes phylum, GpsB is a membrane associated protein that coordinates peptidoglycan synthesis with cell growth and division. Although GpsB has been studied in several bacteria, the structure, function, and interactome of Staphylococcus aureus GpsB is largely uncharacterized. To address this knowledge gap, we solved the crystal structure of the N-terminal domain of S. aureus GpsB, which adopts an atypical, asymmetric dimer, and demonstrates major conformational flexibility that can be mapped to a hinge region formed by a three-residue insertion exclusive to Staphylococci. When this three-residue insertion is excised, its thermal stability increases, and the mutant no longer produces a previously reported lethal phenotype when overexpressed in Bacillus subtilis. In S. aureus, we show that these hinge mutants are less functional and speculate that the conformational flexibility imparted by the hinge region may serve as a dynamic switch to finetune the function of the GpsB complex and/or to promote interaction with its various partners. Furthermore, we provide the first biochemical, biophysical, and crystallographic evidence that the N-terminal domain of GpsB binds not only PBP4, but also FtsZ, through a conserved recognition motif located on their C-termini, thus coupling peptidoglycan synthesis to cell division. Taken together, the unique structure of S. aureus GpsB and its direct interaction with FtsZ/PBP4 provide deeper insight into the central role of GpsB in S. aureus cell division.